Oxandrolone |
Oxandrin |
Oxandrolone Systematic (IUPAC) name 17b-hydroxy-17a-methyl-2-oxa-5a-androstan-3-one Identifiers CAS number 53-39-4 ATC code A14AA08 PubChem 5878 DrugBank APRD01151 Chemical data Formula C19H30O3 Mol. weight 306.44 g/mol Pharmacokinetic data Bioavailability 97% Metabolism Hepatic Half life 8 hours Excretion Urinary:90%; Fecal:6% Therapeutic considerations Pregnancy cat. X Legal status Prescription only (US) Routes Oral Oxandrolone (Oxandrin) ...
Wikipedia - [full article]
Oxandrolone Clinical Trials
- Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome
ClinicalTrials.gov Identifier: NCT00004275 - Active, not recruiting
Turner's Syndrome
- Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00070148 - Active, not recruiting
Quality of Life; weight changes; unspecified adult solid tumor, protocol specific
- Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
ClinicalTrials.gov Identifier: NCT00027391 - Completed
Muscular Dystrophies
- Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia
ClinicalTrials.gov Identifier: NCT00243399 - Recruiting
Fanconi Anemia
- Anabolic Steroid Therapy on Pressure Ulcer Healing in Persons with Spinal Cord Injury
ClinicalTrials.gov Identifier: NCT00101361 - Recruiting
Spinal Cord Injury
- The Effects of Hormones in Growth Hormone-Treated Girls with Turner Syndrome
ClinicalTrials.gov Identifier: NCT00001343 - Completed
Dwarfism; Turner's Syndrome
- Nutrition Intervention in AIDS Wasting
ClinicalTrials.gov Identifier: NCT00006167 - Completed
HIV Wasting Syndrome
Resources
- Oxandrin (Drug Digest)
- Oxandrolone (Drug Digest)

Not Signed In -

